The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo....
NCT ID: NCT07489651 Phase: PHASE2 Enrollment Target: 64 Status: Recruiting
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.
[Draft — editorial context needed]
Dave Asprey's annual biohacking conference featuring cutting-edge health optimization, longevity science, and performance technology demonstrations.
A major biohacking expo focused on wellness, longevity, and biohacking technologies, bringing together practitioners and innovators.
Stay Regulated
New research, honest product reviews, neurotech funding rounds, and events — delivered weekly, with zero sponsors or ads.